Risk adjusted net present value: What is the current valuation of AstraZeneca’s AZD-9574?

AZD-9574 is a small molecule commercialized by AstraZeneca, with a leading Phase II program in Vaginal Cancer.

Harvard’s Stolen Body Parts; Doctors’ Moral Crisis; Fentanyl-Positive Toddler

Note that some links may require subscriptions. The morgue manager of Harvard Medical School was one of several people indicted for stealing brains, skin, and

June 15, 2023

Why Eli Lilly’s earnings didn’t quite live up to the hype

Eventually, the luckiest companies get to deal with a very particular problem: what to do when their stock could be getting ahead of itself. It’s

February 6, 2024

Sticky Patch Defibrillator; State Telehealth Laws and BP Meds; Ketones and HFpEF?

The Jewel patch-wearable cardioverter-defibrillator delivered successful shocks for protection from sudden cardiac arrest, and people were highly compliant to wearing the water-resistant device. (Journal of

July 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.